-
PurposeExpresses C terminally 3xFLAG tagged ZNF598 protein
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 105690 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5059
- Total vector size (bp) 7768
-
Modifications to backboneTEV-3xFLAG was inserted into the vector to serve as a C-terminal tag
-
Vector typeMammalian Expression
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameZNF598
-
Alt namezinc finger protein 598
-
SpeciesH. sapiens (human)
-
Insert Size (bp)2717
-
GenBank IDNM_178167
-
Entrez GeneZNF598 (a.k.a. HEL2)
- Promoter CMV (from vector)
-
Tag
/ Fusion Protein
- TEV-3xFLAG (C terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site XbaI (not destroyed)
- 5′ sequencing primer GGTCTATATAAGCAGAGC
- 3′ sequencing primer GCCTGCTATTGTCTTCCC (Common Sequencing Primers)
Resource Information
-
A portion of this plasmid was derived from a plasmid made byZNF598 CDA was originally cloned from the origene plasmid RC208429.
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-ZNF598-TEV-3xFLAG was a gift from Ramanujan Hegde (Addgene plasmid # 105690 ; http://n2t.net/addgene:105690 ; RRID:Addgene_105690) -
For your References section:
Initiation of Quality Control during Poly(A) Translation Requires Site-Specific Ribosome Ubiquitination. Juszkiewicz S, Hegde RS. Mol Cell. 2017 Feb 16;65(4):743-750.e4. doi: 10.1016/j.molcel.2016.11.039. Epub 2017 Jan 5. 10.1016/j.molcel.2016.11.039 PubMed 28065601